ILMN
Illumina, Inc. · Healthcare · Medical - Diagnostics & Research
Momentum-inputs (vergelijkbare managers): breedte van houders 0.0% · aandelenstroom -6.5% · netto nieuwe posities 0.0% — formule
Alle eigendomscijfers: uitsluitend gevolgde 13F-managers, posities in gewone aandelen, rapportageperiode Q3 2024
| Kwartaal | Houders | Δ | Aandelen | Gerapporteerde waarde | Nieuw | Uitstappen |
|---|---|---|---|---|---|---|
| Q2 2026 | 164 | +8 | 117.28M | $20.61B | +11 | −2 |
| Q1 2026 | 158 | -5 | 113.90M | $14.03B | +5 | −11 |
| Q4 2025 | 162 | 0 | 124.91M | $16.38B | +2 | −1 |
| Q3 2025 | 23 | -1 | 78.13M | $7.41B | +1 | −3 |
| Q2 2025 | 22 | 0 | 71.58M | $6.83B | +1 | −1 |
| Q1 2025 | 19 | 0 | 39.00M | $3.09B | +1 | −1 |
| Q4 2024 | 19 | 0 | 37.37M | $4.99B | +2 | −2 |
| Q3 2024 | 18 | 0 | 20.75M | $2.70B | +1 | −1 |
| Q2 2024 | 18 | — | 22.19M | $2.32B | — | — |
| # | Manager | Aandelen | Δ aandelen | Waarde | Hun gewicht | Gehouden | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Baillie Gifford ✦ | 3.62M | -35.4% | $472.45M | 0.4% | ▼ Trim | 2 | SEC ↗ |
| 2 | Baillie Gifford ✦ | 3.62M | -35.4% | $472.45M | 0.4% | ▼ Trim | 2 | SEC ↗ |
| 3 | Baillie Gifford ✦ | 3.62M | -35.4% | $472.45M | 0.4% | ▼ Trim | 2 | SEC ↗ |
| 4 | Baillie Gifford ✦ | 3.62M | -35.4% | $472.45M | 0.4% | ▼ Trim | 2 | SEC ↗ |
| 5 | Capital World Investors ✦ | 3.54M | +4.8% | $462.18M | 0.1% | ▲ Add | 2 | SEC ↗ |
| 6 | Geode Capital Management ✦ (passief) | 2.73M | +1.8% | $354.93M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 7 | Geode Capital Management ✦ (passief) | 2.73M | +1.8% | $354.93M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 8 | PRIMECAP Management ✦ | 2.52M | +3.6% | $328.16M | 0.2% | ▲ Add | 2 | SEC ↗ |
| 9 | Norges Bank ✦ (passief) | 1.95M | -6.5% | $253.88M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 10 | Millennium Management ✦ | 1.46M | -1.4% | $190.94M | 0.2% | ▼ Trim | 2 | SEC ↗ |
| 11 | Marshall Wace ✦ | 1.24M | +66.7% | $161.68M | 0.2% | ▲ Add | 2 | SEC ↗ |
| 12 | Marshall Wace ✦ | 1.24M | +66.7% | $161.68M | 0.2% | ▲ Add | 2 | SEC ↗ |
| 13 | Two Sigma Investments ✦ | 1.11M | -19.6% | $145.30M | 0.3% | ▼ Trim | 2 | SEC ↗ |
| 14 | Renaissance Technologies ✦ | 1.08M | +8.4% | $141.36M | 0.2% | ▲ Add | 2 | SEC ↗ |
| 15 | AQR Capital Management ✦ | 644.93K | +753.5% | $84.00M | 0.1% | ▲ Add | 2 | SEC ↗ |
| 16 | AQR Capital Management ✦ | 644.93K | +753.5% | $84.00M | 0.1% | ▲ Add | 2 | SEC ↗ |
| 17 | AQR Capital Management ✦ | 644.93K | +753.5% | $84.00M | 0.1% | ▲ Add | 2 | SEC ↗ |
| 18 | AQR Capital Management ✦ | 644.93K | +753.5% | $84.00M | 0.1% | ▲ Add | 2 | SEC ↗ |
| 19 | AQR Capital Management ✦ | 644.93K | +753.5% | $84.00M | 0.1% | ▲ Add | 2 | SEC ↗ |
| 20 | Icahn Capital ✦ | 430.00K | 0.0% | $56.08M | 0.6% | Held | 2 | SEC ↗ |
| 21 | Soros Fund Management ✦ | 175.00K | Nieuw | $22.82M | 0.6% | New | 1 | SEC ↗ |
| 22 | T. Rowe Price ✦ | 112.07K | -0.5% | $14.62M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 23 | T. Rowe Price ✦ | 112.07K | -0.5% | $14.62M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 24 | Gotham Asset Management ✦ | 42.94K | +242.8% | $5.60M | 0.1% | ▲ Add | 2 | SEC ↗ |
| 25 | D. E. Shaw & Co. ✦ | 33.14K | -79.4% | $4.32M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 26 | Wellington Management ✦ | 30.95K | +2.5% | $4.04M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 27 | Wellington Management ✦ | 30.95K | +2.5% | $4.04M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 28 | Citadel Advisors ✦ | 15.84K | -96.3% | $2.07M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 29 | Citadel Advisors ✦ | 15.84K | -96.3% | $2.07M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 30 | GAMCO Investors ✦ | 1.94K | -21.3% | $252,995 | 0.0% | ▼ Trim | 2 | SEC ↗ |
"Hun gewicht" = het aandeel van de positie in de gerapporteerde 13F-aandelenwaarde van die beheerder — de overtuigingsmaatstaf. ✦ = gecureerde beheerder.
Nieuwe kopers
| Soros Fund Management | $22.82M | 0.6% |
Verlaten
| Point72 Asset Management | $15.07M | was 0.1% |
Volledige marktcontext: over ALLE 13F-indieners (SEC gestructureerde data, Q1 2026): 837 houders, 154.80M aandelen, $18.58B gerapporteerd. Dit betreft een andere, oudere periode dan de bovenstaande cijfers van het gevolgde universum; beide worden nooit gecombineerd.
Wat de gevolgde houders van dit effect verder het vaakst bezitten — aantallen gedeeld eigendom, geen fundamentele relaties.
Open-market aankopen (P)
Geen open-market insider-aankopen in ons dekkingsvenster.
Open-market verkopen (S)
Director · 8.19K aand · $1.78M
Director · 86.83K aand · $18.98M
Director · 133.26K aand · $29.25M
Director · 3.88K aand · $854,765
Director · 4.53K aand · $952,918
Director · 7.15K aand · $1.51M
Director · 13.05K aand · $2.78M
Director · 6.82K aand · $1.46M
Director · 13.67K aand · $2.93M
Director · 9.37K aand · $2.02M
Toekenningen, uitoefeningen en belastinginhoudingen worden hier nooit meegeteld als aankopen of verkopen. Methodologie